Literature DB >> 33357707

Based on network pharmacology method to discovered the targets and therapeutic mechanism of Paederia scandens against nonalcoholic fatty liver disease in chicken.

Qiang Wu1, Fan Yang2, Huaqiao Tang3.   

Abstract

The aim of the study is to determine the target of Paeteria scandens in nonalcoholic fatty liver disease (NAFLD). The Chinese herbal medicine pharmacology data and analysis platform were used to search and screen for the effective components of the Paeteria scandens compounds and to analyze the possible therapeutic targets based on network topology. In addition, various known disease target databases were enrolled, the therapeutic target proteins in NAFLD were screened, and a protein-protein interaction network was constructed. Enrichment analysis was performed on key nodes. Finally, the inhibitory effect of Paeteria scandens on NAFLD was verified by experiments. We identified 33 major candidate targets of Paeteria scandens and successfully constructed a "drug-compound-target-disease" network. Abovementioned targets revealed by gene enrichment analysis have played a significant role in the cell cycle, apoptosis, and related signal pathways. We demonstrated that Paeteria scandens downregulated serum triglyceride and lipopolysaccharides levels in NAFLD chickens by feeding with a high-capacity diet and endotoxin of Salmonella enteritidis was given by gavage. Paeteria scandens may regulate the hepatic cell cycle and apoptosis through the Salmonella infection pathway, Toll-like receptor signaling pathway, and apoptosis pathway. For NAFLD, Paeteria scandens may be a promising, long-lasting treatment strategy.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Paeteria scandens; apoptosis; cell cycle; network pharmacology; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2020        PMID: 33357707      PMCID: PMC7772706          DOI: 10.1016/j.psj.2020.09.087

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


Introduction

Nonalcoholic fatty liver disease (NAFLD) is the most common nutrition metabolic disease worldwide. Chicken NAFLD is the disease responsible for the morbidity and/or mortality occurring in the poultry industry (Sánchez-Polo et al., 2015). The estimated prevalence of chicken NAFLD is around 5%, but occasional outbreaks occur in which up to 20% of a flock have been lost (Bannister, 1976). Up to now, NAFLD is becoming an increasingly common medical problem in the poultry industry, which still is associated with the lack of any effective treatment (Martín-Castillo et al., 2010; Glass et al., 2019; Huang et al., 2020). For the treatment of NAFLD, losing weight by exercise or diet remains the standard treatment in human, because no effective pharmacological therapy has yet been developed for NAFLD (Takeda et al., 2016). To apply effective preventive and/or treatment strategies against chicken NAFLD, it is becoming increasingly important to detect the target of drug in NAFLD. Traditional Chinese medicine (TCM) is a valuable part of Chinese excellent traditional culture. It is a collection of 1000 yr of practical experience and has made tremendous contributions to human disease prevention and treatment (Guohua et al., 2017). In clinical application, compared with the exposure to single-target chemical drugs with substantial toxic side-effects and poor therapeutic effects on complex disease (Zhang et al., 2016), TCM reflects multicomponent, multitarget point, and multipathway synergies (Du et al., 2009), and the advantage of TCM are gradually becoming more prominent. At present, the diseases can cause metabolic syndromes, consisting of obesity and dyslipidemia (Takeda et al., 2016). The TCM has been widely used as an alternative treatment for NAFLD, including reducing injury, inhibition of inflammation, and inhibition of apoptosis (Xu, 2006). Paederia scandens belongs to the Medicinal Material in Miao-medicine. A large number of studies have revealed that Paederia scandens has significant clinical effects, including antibiosis, antitoxin, and anti-inflammatory (Qiang et al., 2012). System regulation of TCM is similar to the study thought of network pharmacology. Network pharmacology combines the field of systems biology with pharmacokinetic and pharmacodynamic properties to study drugs, protein targets, and their pharmacological activities (Yameng et al., 2018). This field combines “-omic” (genomics, proteomics, transcriptomics, and metabolomics) profiles and metabolites to construct networks to explore drug mechanisms (Liu et al., 2015). Network pharmacology is based on drug–gene–target–disease interaction networks and systematically observes the effects of drugs on some disease. This approach is in line with the theory that TCM emphasizes the diagnosis and treatment of diseases from a holistic perspective and the synergy between Chinese medicine and its compounds (Ru et al., 2014). Therefore, in this study, we simulated the network relationships between bioactive components of Paederia scandens and their targets based on the network pharmacology method, which was used to clarify the synergistic effect and mechanism of Paederia scandens. In addition, we conducted an experiment to verify the mechanism by which Paederia scandens mediates its therapeutic effect on NAFLD.

Materials and methods

Compounds Profiling and Disease Targets Identification

The bioactive compounds of the Paederia scandens were collected from the Traditional Chinese Medicine Systems Pharmacology (https://tcmspw.com/tcmsp.php) database, Herbal Ingredients Targets Database Introduction (http:lifecenter.sgst.cn/hit/), and Traditional Chinese Medicine Integrated Database (http://www.megabionet.org/tcmid/). Bioavailability and drug likeness were used for the candidate active ingredients screening, and we set bioavailability ≥ 30% and drug likeness ≥ 0.18 as the threshold for candidate active compounds. Afterward, the chicken target points corresponding to the active compounds screened from the Pharmmapper database and PubMed database were standardized in uniProt (https://www.uniprot.org/). Disease-related target points were mined from the Genecards (https://www.genecards.org/) and OMIM (https://omim.org/) databases. All of disease gene targets were normalized with R software using the Bioconductor package when redundancy was deleted (Yu et al., 2012).

Network Establish

Screening for drug-disease crossover genes was performed. Based on previous steps, 2 sets of target lists were prepared: drug-related target points and disease-related target points. The crossover target points were filtered with R software using the Venn Diagram package. The Stringdb database (http://string-db.org/) was used to analyze the intersecting protein–protein interactions (PPI), and the common target points were counted with R software (Guohua et al., 2017). Finally, Cytoscape 3.6.1 software was used, and a “drug-compound-target-disease” network was constructed.

Bioinformatic Annotation

The proteins with overlapping expression patterns were evaluated by bioinformatic annotation with R software using the Bioconductor package, including a Gallus database, PPI analysis (https://string-db.org), a gene ontology annotation database website (http://www.geneontology.org), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis (http://www.genome.jp/kegg/).

Animals and Experimental Design

Thirty-six, 1-day-old, healthy Ross 305 chicks (33–40 g) were selected from the breeding chicken farm of Hunan Huaihua JinSheng Livestock Co., Ltd. (Huaihua, China). All chickens were housed in wood cages under the recommended environment. Chicks were brooded at 33°C during the first week; the brooding temperature was reduced 3°C/wk to approximately 24°C by week 4 of age. Light was provided continually using incandescent lamps. The environmental humidity was controlled at 60 to 65%. The chickens were randomly divided into control group, model group, and drug-treated group, 12 individuals per group, and all groups were given a high-capacity diet in the experimental process. Cooked pigs' oil was the main calorie sources of the high-capacity diet. Meanwhile, model group was fed the diet mixed with 5% dose Paederia scandens. Endotoxin of Salmonella enteritidis 0.3 mL, with 1.0 × 109 cfu/mL and making 60 times by ultrasonic processing at 40 Hz for 20 s, was given into the model group and drug-treated group every week by gavage, respectively, and distilled water was given in control group at the same way. The dose of endotoxin of S. enteritidis was calculated by previous experiments, and 0.1 mL per chick was the safe and effective dose to treat NAFLD in chicken (Yu et al., 2012). The high-capacity diet formulations are shown in Table 1. All chickens were given free access to laboratory feed and water for 5 wk, and the chickens had no access to food for 12 h before they were anesthetized and sacrificed. Five chickens were randomly selected and weighted (Table 2), and at each blood sampling, 6 mL of blood were taken by syringe from the wing vein and gently transferred into blood tubes. Afterward, 5 chickens were killed in each group, and the lives were excised and removed promptly for further analysis. All the animal tests were in accordance with the Administration of Affairs Concerning Experimental Animals of the State Council of the People's Republic of China. The experiment protocol was approved by the Committee on Experimental Animal Management of Tongren Polytechnic College in Guizhou (with protocol No. 2016051407).
Table 1

Composition and nutrient levels of the diets.

IngredientsProportion (%)Nutritional level
Corn53.00ME16.07 (MJ/kg)
Fish meal1.00CP160.0 (g/kg)
Fried meal29.30Ca9.0 (g/kg)
Cooked pigs' oil12.95AP3.5 (g/kg)
Additives0.75Lys10.0 (g/kg)
Lys0.12Met3.8 (g/kg)
Met0.12
CaHPO41.11
Limestone meal1.52
Salt0.13

The additives contains 0.50% of microelements, per kg dietary contains Fe 80 mg, Zn 40 mg, Cu 8 mg, Mn 60 mg, I 0.35 mg, Se 0.15 mg, 0.20% of choline, Va 1,500 IU, VD3 200 IU, VE 10 IU, VK3 0.05 mg, VB1 1.80 mg, VB2 3.60 mg, VB12 0.01 mg, VB7 0.15 mg, VB9 0.55 mg, VB5 35 mg, VB3 10 mg, VB6 3.50 mg.

Table 2

The mortality and weight gain in the fifth wk.

GroupsNumbersMortality %Mean mass gain (kg)
Control group1202.190 ± 0.86
Model group12171.904 ± 0.66∗∗
Drug group1202.015 ± 0.72

∗∗Means P < 0.01 vs. control group.

Composition and nutrient levels of the diets. The additives contains 0.50% of microelements, per kg dietary contains Fe 80 mg, Zn 40 mg, Cu 8 mg, Mn 60 mg, I 0.35 mg, Se 0.15 mg, 0.20% of choline, Va 1,500 IU, VD3 200 IU, VE 10 IU, VK3 0.05 mg, VB1 1.80 mg, VB2 3.60 mg, VB12 0.01 mg, VB7 0.15 mg, VB9 0.55 mg, VB5 35 mg, VB3 10 mg, VB6 3.50 mg. The mortality and weight gain in the fifth wk. ∗∗Means P < 0.01 vs. control group.

TG and LPS Assays

Standing for 5 min, the serum of blood sampling were collected, the centrifuge condition of which is rotation speed 4,000 r/min and time 5 min, and preserved at −20°C for triglyceride (TG) and lipopolysaccharides (LPS). The levels of TG and LPS were measured by assays kits from the Nanjing Jiancheng Bioengineering Research Institute (Nanjing, China).

Detection of Hepatic Apoptosis and Cell Cycle

Freshly excised liver tissue was washed with normal saline on ice, dried it with filter paper. Approximately, 1 g of the liver was transferred to 10 mL of ice-cold PBS solution containing 1.25 mg/mL Type IV collagenase (Biochrom, Berlin, Germany), minced using a scalpel blade, and teased apart into a single cell suspensions which were incubated at 37°C for 30 min with occasional gentle mixing by inversion, followed by triturating by gentle pipetting, filtering first through 100 μm and then 40 μm cell strainers (Becton Dickinson, Franklin Lakes, NJ) and adjusting cell density to 5 × 106 cell/mL in the incubation buffer, and resuspended in PBS to a final concentration of 1 × 106 cells/mL. 1 × 106 cells were incubated with 5 μL Annexin V-FITC and 5 μL PI (propidium iodide) for 30 min at 4°C according to the manufacturer's instructions. The cells were diluted with the incubation buffer to a final volume of 600 μL, and stained cells were analyzed by FACSCalibur (BD Biosciences) using 488 nm excitation and 515 nm band-pass filter for fluorescein detection (FL1) and a filter > 600 nm for PI detection (FL2). Data were collected for 10,000 cells, and the number of the cells in each stage was calculated with the ModFit LT cell cycle analysis program (Verity Software House), and apoptosis was calculated using CellQuest software from BD Biosciences according to the manufacturer's instructions. Annexin V-FITC and PI were provided by Sigma.

Statistical Analysis

Statistical analysis was performed using PASW statistics 19.0 software package (ICM, Armonk, NY). The data were presented as means and standard deviation (means ± SD), and group comparison was done by independent-sample t test.

Results

The Assumed Targets of Paederia scandens and NAFLD

In the present study, we collected a total of 11 compounds from Paederia scandens (Supplementary Table 1) according to the screening conditions. The number of targets of each compound is different, the targets overlap significantly among, therefore a network is utilized in treatment with the compounds of Paederia scandens. We found 97 target proteins (Supplementary Table 2) which were added symbol by chicken target points database from 357 target points with these compounds. The effectiveness of Paederia scandens in preventing and controlling NAFLD depends on the synergy between multiple compounds and their target points. For the disease target identification, we collected NAFLD-related target points from the GeneCards and OMIM databases. And topological analysis of protein interaction network nodes, including screening key nodes to remove duplicates, revealed a total of 1,309 target points.

Network Analysis of Targets

In an R software analysis, all the drug target points and disease-related target points were listed as 2 independent sets. The closed-loop form of the fixed position was used to represent the set and its relationship to obtain a Venn diagram, as shown in Supplementary Figure 1. We obtained a total of 33 interaction target points, and we used String-db (https://string-db.org/) to obtain the PPI among 132 simulated target points, as shown in Supplementary Table 3. At the same time, we constructed an interactive drug–compound–target–disease network (Figure 1). Quercetin and kaempferol are used as ingredients in Paederia scandens, which is the main therapeutic candidates for NAFLD. Their potency was crucial to Paederia scandens. As shown in Supplementary Table 3, the targets of Paederia scandens include 33 of the 132 intersecting targets screened previously. These results further demonstrate that quercetin and kaempferol played a critical role in the biological activity of Paederia scandens.
Figure 1

Network analysis of targets. “drug–compound–target–disease” network. Blue indicates drug–disease intersection targets. Red indicates NAFLD disease, and other colors indicate active compounds. Abbreviation: NAFLD, nonalcoholic fatty liver disease.

Network analysis of targets. “drug–compound–target–disease” network. Blue indicates drug–disease intersection targets. Red indicates NAFLD disease, and other colors indicate active compounds. Abbreviation: NAFLD, nonalcoholic fatty liver disease.

Predicting Functional Enrichment Analysis for Paederia scandens

Gene ontology annotation revealed that the expressed drug–disease crossover targets were mainly associated with cofactor binding, heme binding, oxidoreductase activity, tetrapyrrole binding, and cytokine activity (Figure 2A). Moreover, KEGG enrichment analysis showed that many target genes were strongly associated with AGE-RAGE signaling pathway in diabetic complications, focal adhesion, mitogen-activated protein kinase signaling pathway, C-type lectin receptor signaling pathway, apoptosis, Salmonella infection, and toll-like receptor signaling pathway (Figure 2B). Intestinal factors are known to be one of the major causes of NAFLD. Our analysis showed that the important target genes were mainly distributed in the Salmonella infection pathway (Figure 3A), Toll-like receptor signaling pathway (Figure 3B), and apoptosis pathway (Figure 3C), which belong to endotoxin-induced hepatitis or intestinal inflammation. These findings explain the molecular mechanism underlying the results that most of the active molecules were associated with intestinal infection and NAFLD, suggesting that Paederia scandens may treat NAFLD through antitoxin and anti-inflammatory effects. Based on the molecular mechanisms of these predictions and the results of the network analysis, we designed experiments to verify our hypothesis at the cellular level.
Figure 2

Bioinformatic analyses of drug-disease intersection proteins. (A) Gene ontology annotations; (B) KEGG annotation. Abbreviation: KEGG, Kyoto Encyclopedia of Genes and Genomes.

Figure 3

Intestinal infection was mainly distributed in the enteritis and NAFLD. (A) the Salmonella infection pathway; (B) Toll-like receptor signaling pathway; (C) apoptosis pathway. Abbreviation: NAFLD, nonalcoholic fatty liver disease.

Bioinformatic analyses of drug-disease intersection proteins. (A) Gene ontology annotations; (B) KEGG annotation. Abbreviation: KEGG, Kyoto Encyclopedia of Genes and Genomes. Intestinal infection was mainly distributed in the enteritis and NAFLD. (A) the Salmonella infection pathway; (B) Toll-like receptor signaling pathway; (C) apoptosis pathway. Abbreviation: NAFLD, nonalcoholic fatty liver disease.

Clinical Symptoms

The clinical manifestations were weight gain, unstable standing, mouth breathing, lethargy, unilateral lying, increased body temperature, and feces rot in most of the NAFLD chickens treated with endotoxin of Salmonella enteritidis. Even a small number of chickens died in model group. There was no chicken death in control group and drug-treated group, and no obvious clinical features in drug-treated group.

Serum TG and LPS Levels

The results showed that serum TG levels were significantly higher in model group than control group (P < 001), and serum LPS levels were significantly higher in model group than control group (P < 0.01). Serum TG and LPS levels were lower in drug-treated group than in model group. Endotoxin of Salmonella enteritidis significantly upregulated the TG and LPS levels in NAFLD, and Paederia scandens downregulated their levels. The results are listed in Table 3.
Table 3

Contents of TG (mmol/L) and LPS(EU/mL) in serum.

GroupsControl groupModel groupDrug group
TG0.52 ± 0.150.99 ± 0.20∗∗0.60 ± 0.33
LPS0.06 ± 0.000.09 ± 0.01∗∗0.07 ± 0.01

∗∗means P < 0.01 vs. control group.

Contents of TG (mmol/L) and LPS(EU/mL) in serum. ∗∗means P < 0.01 vs. control group.

The Hepatic Cell Cycle and Apoptosis

The present study showed that the proportion of hepatocytes at Gap 0/1 (G0/1) phase were higher in model group than in control group (P < 0.05), and Paederia scandens downregulated it. The proportion of hepatocytes at S phase (S) and Gap 2/M (G2M) phase were upregulated by Paederia scandens significantly when compared with control group and model group (P < 0.01 or P < 0.05). The proportion of apoptosis was higher in drug group than in control group (P < 0.01), and the proportion of apoptosis was smaller in model group than in control group (Table 4). Proliferation index (PI) and S-phase fraction (SPF) were lower in model group than in control group, and Paederia scandens significantly upregulated them in drug group than in control group (P < 0.05 or P < 0.01). The PI and SPF were calculated as follow: , .
Table 4

The cell cycles and apoptosis of the liver cell (%).

ItemControl groupModel groupDrug group
G0/170.67 ± 2.7674.92 ± 2.28∗72.83 ± 4.89
S7.51 ± 3.296.32 ± 2.8411.46 ± 2.08∗∗
G2M7.84 ± 0.887.34 ± 1.649.53 ± 2.16∗
apoptosis11.82 ± 2.6811.42 ± 2.698.34 ± 3.25∗∗
PI17.41 ± 3.6515.42 ± 2.9722.90 ± 3.42∗
SPF8.52 ± 3.427.13 ± 2.6612.50 ± 2.78∗∗

Abbreviations: PI, proliferation index; SPF, S-phase fraction.

∗P < 0.05

∗∗P < 0.01 vs. control group.

The cell cycles and apoptosis of the liver cell (%). Abbreviations: PI, proliferation index; SPF, S-phase fraction. ∗P < 0.05 ∗∗P < 0.01 vs. control group.

Discussion

The study of the pharmacodynamics of Chinese medicine compound substances and their mechanisms of action is one of the key scientific issues in the modernization of TCM (Shu et al., 2018). Network pharmacology and systems biology can explain the effects of drugs on bio-net from the perspective of macroscopic or overall regulation and provide new research ideas and technical means for the study of the mechanisms of action of Chinese medicine compound (Chen et al., 2014). In this study, in view of the complexity of the active ingredients in Paederia scandens and the diversity of potential regulatory targets in chicken, we first collected a summary of the target points of the compounds in Paederia scandens and NAFLD-related target points from multiple databases in chicken with network pharmacology analysis. Then, the drug–compound–target–disease network was constructed, and the potential target points of Paederia scandens were predicted. Our research found that the main active ingredients of Paederia scandens with cofactor binding, heme binding, oxidoreductase activity, tetrapyrrole binding, and cytokine activity. In the KEGG enrichment assay, we observed that many target points might associated with AGE-RAGE signaling pathway in diabetic complications, Focal adhesion, mitogen-activated protein kinase signaling pathway, C-type lectin receptor signaling pathway, apoptosis, Salmonella infection, and Toll-like receptor signaling pathway. In addition, intestinal factors are known to be one of the major causes of NAFLD, and the Salmonella infection pathway, Toll-like receptor signaling pathway, and apoptosis pathway belong to endotoxin-induced hepatitis or intestinal inflammation. These findings might explain the molecular mechanism underlying the results that most of the active molecules were associated with intestinal infection and NAFLD, suggesting that Paederia scandens may treat NAFLD-related intestinal factor. For our further study, we confirmed that the protection of Paederia scandens in NAFLD model concomitant with diseases caused by endotoxin of S. enteritidis. The results showed Paederia scandens can reduce death rate, promote living quality, and downregulate serum TG and LPS levels in NAFLD chickens. These finding demonstrated Paederia scandens has an important treatment value for NAFLD. The SPF is an index of liver regeneration, and PI is a proportion of during proliferation of hepatocytes (Qiang et al., 2008), and increasing PI and SPF showed that hepatocytes grew up actively. Paederia scandens can also upregulated PI and SPF of hepatocyte and reduce the proportion of apoptosis in NALFD chicken. The NAFLD research had shown that pathogenesis of NAFLD is the 2 hit hypotheses (Byrne, 2010). This observation also provides us with new direction and possibilities for further exploration for the mechanism for inhibiting NAFLD by Paederia scandens. Our enrichment analysis indicates that the regulation of apoptosis, Salmonella infection, and Toll-like receptor signaling pathway may be the key mechanism for inhibiting NAFLD by Paederia scandens, and quercetin and kaempferol are used as ingredients in Paederia scandens, which is the main therapeutic candidates for NAFLD. In conclusion, quercetin and kaempferol of Paederia scandens are used as ingredients and the main therapeutic candidates for NAFLD and targeting the Salmonella infection pathway, Toll-like receptor signaling pathway, and apoptosis pathway may be a potential therapeutic approach for NAFLD by Paederia scandens.

DISCLOSURE

The authors declare no conflict of interest.
  12 in total

1.  clusterProfiler: an R package for comparing biological themes among gene clusters.

Authors:  Guangchuang Yu; Li-Gen Wang; Yanyan Han; Qing-Yu He
Journal:  OMICS       Date:  2012-03-28

2.  Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC/LC-MS based metabolomics and network pharmacology approaches.

Authors:  Si Chen; Si Wu; Wuhong Li; Xiaofei Chen; Xin Dong; Guangguo Tan; Hai Zhang; Zhanying Hong; Zhenyu Zhu; Yifeng Chai
Journal:  Mol Biosyst       Date:  2014-12

3.  Effect of diet/atorvastatin on atherosclerotic lesions associated to nonalcoholic fatty liver disease in chickens.

Authors:  Maria T Sánchez-Polo; María T Castells; Bartolomé García-Pérez; Antonia Martín; Gracia Adánez; Ignacio Ayala
Journal:  Histol Histopathol       Date:  2015-06-24       Impact factor: 2.303

Review 4.  Fatty liver: role of inflammation and fatty acid nutrition.

Authors:  Christopher D Byrne
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-02       Impact factor: 4.006

5.  Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens.

Authors:  Antonia Martín-Castillo; Maria Teresa Castells; Gracia Adánez; Maria Teresa Sánchez Polo; Bartolomé García Pérez; Ignacio Ayala
Journal:  Biomed Pharmacother       Date:  2009-10-22       Impact factor: 6.529

6.  The biochemistry of fatty liver and kidney syndrome. Biotin-mediated restoration of hepatic gluconeogenesis in vitro and its relationship to pyruvate carboxylase activity.

Authors:  D W Bannister
Journal:  Biochem J       Date:  1976-04-15       Impact factor: 3.857

7.  Clarifying of the potential mechanism of Sinisan formula for treatment of chronic hepatitis by systems pharmacology method.

Authors:  Zhiming Shu; Wang He; Mohamed Shahen; Zihu Guo; Jia Shu; Tiantian Wu; Xiaoyu Bian; Akhtar Hussain Shar; Mayada Ragab Farag; Mahmoud Alagawany; Chaobin Liu
Journal:  Biomed Pharmacother       Date:  2018-02-23       Impact factor: 6.529

Review 8.  [Incretin as a Novel Treatment Strategy for NAFLD/NASH].

Authors:  Yasuo Takeda; Ryuji Ikeda; Tomoko Kondo
Journal:  Yakugaku Zasshi       Date:  2016       Impact factor: 0.302

9.  Network pharmacology-based identification of key pharmacological pathways of Yin-Huang-Qing-Fei capsule acting on chronic bronchitis.

Authors:  Guohua Yu; Yanqiong Zhang; Weiqiong Ren; Ling Dong; Junfang Li; Ya Geng; Yi Zhang; Defeng Li; Haiyu Xu; Hongjun Yang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-22

10.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.

Authors:  Jinlong Ru; Peng Li; Jinan Wang; Wei Zhou; Bohui Li; Chao Huang; Pidong Li; Zihu Guo; Weiyang Tao; Yinfeng Yang; Xue Xu; Yan Li; Yonghua Wang; Ling Yang
Journal:  J Cheminform       Date:  2014-04-16       Impact factor: 5.514

View more
  1 in total

1.  Integrating Network Pharmacology and Molecular Docking to Analyse the Potential Mechanism of action of Macleaya cordata (Willd.) R. Br. in the Treatment of Bovine Hoof Disease.

Authors:  Zhen Dong; Mengting Liu; Xianglin Zou; Wenqing Sun; Xiubin Liu; Jianguo Zeng; Zihui Yang
Journal:  Vet Sci       Date:  2021-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.